Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Nearly 1 in 3 patients with one to two nonadvanced adenomas are being scheduled for follow-up colonoscopies sooner than current guidelines recommend. A large study found that endoscopists followed the 2020 updated 7–10-year surveillance interval for this group only 68%–72% of the time, compared to over 90% adherence for patients with three to four adenomas. The findings raise real concerns about over-surveillance in low-risk patients.
A large study out of Kaiser Permanente found that endoscopists are frequently scheduling follow-up colonoscopies sooner than guidelines recommend for patients with one to two nonadvanced adenomas — a low-risk group that the 2020 US Multi-Society Task Force says should wait 7–10 years between screenings. The study analyzed over 41,000 patients across 281 endoscopists and found that guideline adherence for this group hovered between 68% and 72% from 2021 to 2024.
By contrast, patients with three to four nonadvanced adenomas fared much better — endoscopists followed the recommended 3–5-year interval more than 90% of the time. The gap suggests that clinicians may be applying more caution than necessary for lower-risk patients, potentially driving unnecessary procedures.
Key Takeaways:
Why it matters: Over-surveillance means more colonoscopies than necessary, adding costs, procedural risks, and patient burden — without clear clinical benefit for low-risk individuals. Clearer, more specific guideline intervals could help close the gap.